ApoE Promotes the Proteolytic Degradation of Aβ

Jiang, Qingguang, Lee, C.Y. Daniel, Mandrekar, Shweta, Wilkinson, Brandy, Cramer, Paige, Zelcer, Noam, Mann, Karen, Lamb, Bruce, Willson, Timothy M., Collins, Jon L., Richardson, Jill C., Smith, Jonathan D., Comery, Thomas A., Riddell, David, Holtzman, David M., Tontonoz, Peter, Landreth, Gary E.·2008·Neuron
DOI 10.1016/j.neuron.2008.04.010

Cited by (875)

Items 501–600 of 875

  1. Exploration of 16 candidate genes identifies the association of IDE with Alzheimer's disease in Han Chinese
    Fen Wang, Chang Shu, Longfei Jia, Xiumei Zuo, Yong‐Biao Zhang, Aihong Zhou, Wei Qin, Haiqing Song, Cuibai Wei, Feng Zhang et al. · 2010 · Neurobiology of Aging
  2. Calpain Inhibition as a Potential Treatment of Alzheimer's Disease
    Godfrey S. Getz · 2012 · American Journal Of Pathology
  3. Liver X receptor agonist treatment significantly affects phenotype and transcriptome of APOE3 and APOE4 Abca1 haplo-deficient mice
    Carter, Alexis Y., Letronne, Florent, Fitz, Nicholas F., Mounier, Anais, Wolfe, Cody M., Nam, Kyong Nyon, Reeves, Valerie L., Kamboh, Hafsa, Lefterov, Iliya, Koldamova, Radosveta · 2017 · PLOS ONE
  4. A blood-based signature of cerebrospinal fluid Aβ1–42 status
    Benjamin Goudey, Bowen John Fung, Christine Schieber, Noel Garry Faux, Michael Walter Weiner, Paul S. S. Aisen, Ronald Carl Petersen, Clifford R. Jack, William J. Jagust, John Q. Trojanowki et al. · 2019 · Scientific Reports
  5. Identification of a Chrysanthemic Ester as an Apolipoprotein E Inducer in Astrocytes
    Jianjia Fan, Shahab Zareyan, Wenchen Zhao, Yoko Shimizu, Tom A. Pfeifer, Jun‐Hyung Tak, Murray B. Isman, Bernard G. Van den Hoven, Mark E. Duggan, Michael W. Wood et al. · 2016 · PLoS ONE
  6. Effect of rosiglitazone on amyloid precursor protein processing and Aβ clearance in streptozotocin-induced rat model of Alzheimer's disease.
    Li Wang, Wei Liu, Ying Fan, Tingting Liu, Chunjiang Yu · 2017 · Europe PMC (PubMed Central)
  7. Genetic predictors of outcome following traumatic brain injury
    Robert H. Lipsky, Mingkuan Lin · 2015 · Handbook of clinical neurology
  8. Synthesis and Identification of New Flavonoids Targeting Liver X Receptor β Involved Pathway as Potential Facilitators of Aβ Clearance with Reduced Lipid Accumulation
    Yun Hu, Yaqi Yang, Yanjun Yu, Gesi Wen, Nana Shang, Wei Zhuang, Dihan Lu, Binhua Zhou, Baoxia Liang, Xin Yue et al. · 2013 · Journal of Medicinal Chemistry
  9. Impact of Age on the Cerebrovascular Proteomes of Wild-Type and Tg-SwDI Mice
    James L. Searcy, Thierry Le Bihan, Natalia Salvadores, James McCulloch, Karen J. Horsburgh · 2014 · PLoS ONE
  10. The serine protease HtrA1 contributes to the formation of an extracellular 25-kDa apolipoprotein E fragment that stimulates neuritogenesis
    Sonia Sanz Muñoz, Hongyun Li, Kalani R. Ruberu, Qian Chu, Alan Saghatelian, Lezanne Ooi, Brett Garner · 2018 · Journal of Biological Chemistry
  11. 5-HT3 Antagonist Ondansetron Increases apoE Secretion by Modulating the LXR-ABCA1 Pathway
    Motoko Shinohara, Mitsuru Shinohara, Jing Zhao, Yuan Fu, Chia‐Chen Liu, Takahisa Kanekiyo, Guojun Bu · 2019 · International Journal of Molecular Sciences
  12. New Hope from an Old Drug: Fighting Alzheimer's Disease with the Cancer Drug Bexarotene (Targretin)?
    Giorgio Aicardi · 2013 · Rejuvenation Research
  13. MicroRNAs in brain cholesterol metabolism and their implications for Alzheimer's disease
    Yoon, Hyejin, Flores, Luis F., Kim, Jungsu · 2016 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
  14. Activation of LXRβ Signaling in the Amygdala Confers Anxiolytic Effects Through Rebalancing Excitatory and Inhibitory Neurotransmission upon Acute Stress
    Wen Yu, Lu Wang, Le Yang, Yanjiao Li, Min Wang, Chen Qiu, Qi Yang, Xubo Li, Yunlong Huang, Rui Liu et al. · 2020 · Neurotherapeutics
  15. The LXR agonist GW3965 increases apoA-I protein levels in the central nervous system independent of ABCA1
    Sophie K. Stukas, Sharon May, Anna Wilkinson, Jeniffer Y. Chan, James J. Donkin, Cheryl Lea Wellington · 2011 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
  16. Efficient Processing of Alzheimer's Disease Amyloid-Beta Peptides by Neuroectodermally Converted Mesenchymal Stem Cells
    Hansjörg Habisch, Benjamin Schmid, Christine A. F. Von Arnim, Albert Christian Ludolph, Rolf Erwin Brenner, Alexander Storch · 2009 · Stem Cells and Development
  17. A pleiotropic effect of the APOE gene: association of APOE polymorphisms with multibacillary leprosy in Han Chinese from Southwest China
    D. Wang, Dengfeng Zhang, Guiyun Li, R. Bi, Yu Fan, Yong Wu, Xiaohan Yu, Heng Long, Y.‐Y. Li, Yong‐Gang Yao · 2017 · British Journal of Dermatology
  18. Apolipoprotein E ablation decreases synaptic vesicular zinc in the brain
    Joo‐Yong Lee, Eunsil Cho, Tae-Youn Kim, Dong‐Kyu Kim, Richard D. Palmiter, Irene Volitakis, Jong S. Kim, Ashley Ian Bush, Jae‐Young Koh · 2010 · BioMetals
  19. High-density lipoprotein-related cholesterol metabolism in Alzheimer's disease
    Pedrini, Steve, Chatterjee, Pratishtha, Hone, Eugene, Martins, Ralph N. · 2021 · Journal of Neurochemistry
  20. Cognitive Impairment in Neurological Diseases: Lessons from Apolipoprotein E
    Jiong Shi, Pengcheng Han, Sandra M. Kuniyoshi · 2013 · Journal of Alzheimer s Disease
  21. Neurosteroids and Oxysterols as Potential Therapeutic Agents for Glaucoma and Alzheimer’s Disease
    Makoto Ishikawa, Takeshi Yoshitomi, Douglas F. Covey, Charles F. Zorumski, Yukitoshi Izumi · 2018 · Neuropsychiatry
  22. Apolipoprotein E Interferes with IAPP Aggregation and Protects Pericytes from IAPP-Induced Toxicity
    Anna L. Gharibyan, Tohidul Islam, Nina Pettersson, Solmaz Surano, Johanna Lundgren, Gabriella Johansson, Mélany Genot, Nina Schultz, Malin Wennström, Anders Olofsson · 2020 · Biomolecules
  23. Identification of Side Chain Oxidized Sterols as Novel Liver X Receptor Agonists with Therapeutic Potential in the Treatment of Cardiovascular and Neurodegenerative Diseases
    Na Zhan, Boyang Wang, Nikita Martens, Yankai Liu, Shangge Zhao, Gardi J. Voortman, Jeroen van Rooij, Frank P. J. Leijten, Tim Vanmierlo, Folkert Kuipers et al. · 2023 · International Journal of Molecular Sciences
  24. An ABCA1-independent pathway for recycling a poorly lipidated 8.1 nm apolipoprotein E particle from glia
    Fan, Jianjia, Stukas, Sophie, Wong, Charmaine, Chan, Jennifer, May, Sharon, DeValle, Nicole, Hirsch-Reinshagen, Veronica, Wilkinson, Anna, Oda, Michael N., Wellington, Cheryl L. · 2011 · Journal of Lipid Research
  25. Liver X receptors and cholesterol metabolism: role in ventral midbrain development and neurodegeneration
    Spyridon Theofilopoulos, Ernest Arenas · 2015 · F1000Prime Reports
  26. Cell type-specific functions of Alzheimer's disease endocytic risk genes
    Maninger, Johanna-Katharina, Nowak, Karolina, Goberdhan, Srilakshmi, O'Donoghue, Rachel, Connor-Robson, Natalie · 2024 · Philosophical Transactions of the Royal Society B: Biological Sciences
  27. Myelin-reactive B cells exacerbate CD4+ T cell-driven CNS autoimmunity in an IL-23-dependent manner
    Fazazi, Mohamed Reda, Doss, Prenitha Mercy Ignatius Arokia, Pereira, Resel, Fudge, Neva, Regmi, Aryan, Joly-Beauparlant, Charles, Akbar, Irshad, Yeola, Asmita Pradeep, Mailhot, Benoit, Baillargeon, Joanie et al. · 2024 · Nature Communications
  28. The APOE–Microglia Axis in Alzheimer’s Disease: Functional Divergence and Therapeutic Perspectives—A Narrative Review
    Aiwei Liu, Tingyue Wang, Liu Yang, Yu Zhou · 2025 · Brain Sciences
  29. Current View from Alzheimer Disease to Type 2 Diabetes Mellitus
    Mahmood Rasool, Arif Malik, Aamer Mahmood Qazi, ISHFAQ AHMAD SHEIKH, Abdul Manan, Sumaira Shaheen, Mahmood Husain Qazi, Adeel Chaudhary, Adel Mohammed Abuzenadah, Muhammad Asif et al. · 2014 · CNS & Neurological Disorders - Drug Targets
  30. Epigenetic Regulation of SNAP25 Prevents Progressive Glutamate Excitotoxicty in Hypoxic CA3 Neurons
    Suryanarayan Biswal, Debashree Das, Kalpana Kumari Barhwal, Ashish Kumar, Tapas Chandra Nag, Mahendra Kumar Thakur, Sunil Kumar Hota, Bhuvnesh Kumar · 2016 · Molecular Neurobiology
  31. The p38 mitogen activated protein kinase regulates β-amyloid protein internalization through the α7 nicotinic acetylcholine receptor in mouse brain
    Kaige Ma, Jia Lv, Weina Yang, Ke-Wei Chang, Xiaodan Hu, Lili Shi, Wan-Ying Zhai, Hang-Fan Zong, Yi‐Hua Qian · 2017 · Brain Research Bulletin
  32. Therapies for Alzheimer’s disease: a metabolic perspective
    Raquel Domingues, Cláudia Pereira, Maria Teresa Cruz, Ana Silva · 2021 · Molecular Genetics and Metabolism
  33. Does Alzheimer's disease stem in the gastrointestinal system?
    Pariya Khodabakhsh, Maryam Bazrgar, Leila Dargahi, Fatemeh Mohagheghi, Afsaneh Asgari Taei, Siavash Parvardeh, Abolhassan Ahmadiani · 2021 · Life Sciences
  34. APOE 4 and Cognitive Dysfunction in Multiple Sclerosis: A Review
    Omar Ghaffar, Anthony Feinstein · 2010 · Journal of Neuropsychiatry
  35. Neuronal cholesterol esterification by ACAT1 in Alzheimer's disease
    Ta‐Yuan Chang, Catherine C.Y. Chang, Elena Y. Bryleva, Maximillian A. Rogers, Stephanie R Murphy · 2010 · IUBMB Life
  36. Neurovascular Alterations in Alzheimer’s Disease: Transporter Expression Profiles and CNS Drug Access
    Mitchell P. McInerney, Jennifer Lynn Short, Joseph A. Nicolazzo · 2017 · The AAPS Journal
  37. Association Between Common Variants of APOE , ABCA7 , A2M , BACE1 , and Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease: Data from the PUMCH Dementia Cohort
    Liling Dong, Chenhui Mao, Caiyan Liu, Jie Li, Xinying Huang, Jie Wang, Dan Lei, Shanshan Chu, Longze Sha, Qi Xu et al. · 2021 · Journal of Alzheimer s Disease
  38. Impact of APOE genotype on prion-type propagation of tauopathy
    Tristan Williams, Alejandra Jolie Ruiz, Angelica Maria Ruiz, Quan Vo, Wangchen Tsering, Guilian M. Xu, Karen N. McFarland, Benoit I. Giasson, Patrick M. Sullivan, David Borchelt et al. · 2022 · Acta Neuropathologica Communications
  39. Activation of Liver X Receptors and Peroxisome Proliferator-Activated Receptors by Lipid Extracts of Brown Seaweeds: A Potential Application in Alzheimer’s Disease?
    Nikita Martens, Na Zhan, Gardi J. Voortman, Frank P. J. Leijten, Connor van Rheenen, Suzanne van Leerdam, Xicheng Geng, Michiel Huybrechts, Hongbing Liu, Johan W. Jonker et al. · 2023 · Nutrients
  40. Understanding the Role of miR-33 in Brain Lipid Metabolism: Implications for Alzheimer's Disease
    Jaouen, Florence, Gascon, Eduardo · 2016 · The Journal of Neuroscience
  41. Altered effective connectivity anchored in the posterior cingulate cortex and the medial prefrontal cortex in cognitively intact elderly APOE ε4 carriers: a preliminary study
    Alzheimer’s Disease Neuroimaging Initiative, Xiao Luo, Kaicheng Li, Yunlu Jia, Qingze Zeng, Yeerfan Jiaerken, Tiantian Qiu, Peiyu Huang, Xiaojun Xu, Zhujing Shen et al. · 2018 · Brain Imaging and Behavior
  42. 7,8-Dihydroxyflavone Ameliorates Cognitive Impairment by Inhibiting Expression of Tau Pathology in ApoE-Knockout Mice
    Yang Tan, Shuke Nie, Wende Zhu, Fang Liu, Hailong Guo, Jiewen Chu, Xue Bin Cao, Xingjun Jiang, Yunjian Zhang, Yuzhen Li · 2016 · Frontiers in Aging Neuroscience
  43. Deciphering the role of APOE in cerebral amyloid angiopathy: from genetic insights to therapeutic horizons
    Hantian Hu, Siqi Wan, Yuetao Hu, Qi Wang, Hanyu Li, Nan Zhang · 2025 · Annals of Medicine
  44. Cholesterol Metabolism in CNS Diseases: The Potential of SREBP2 and LXR as Therapeutic Targets
    Wang, Ning-Qi, Sun, Pei-Xiang, Shen, Qi-Qi, Deng, Meng-Yan · 2025 · Molecular Neurobiology
  45. Apolipoprotein E increases cell association of amyloid-β 40 through heparan sulfate and LRP1 dependent pathways
    Paul W. O'Callaghan, Fredrik Noborn, Dag Sehlin, Jin‐Ping Li, Lars Lannfelt, Ulf Lindahl, Xiao Zhang · 2014 · Amyloid
  46. Associative Interactions among Zinc, Apolipoprotein E, and Amyloid-β in the Amyloid Pathology
    Shin Bi Oh, Jung Ah Kim, SuJi Park, Joo‐Yong Lee · 2020 · International Journal of Molecular Sciences
  47. Protein-based HDL subspecies: Rationale and association with cardiovascular disease, diabetes, stroke, and dementia
    Frank M. Sacks, Jeremy D. Furtado, Majken K. Jensen · 2022 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
  48. Effect of seabuckthorn seed protein and its arginine-enriched peptides on combating memory impairment in mice
    Xiping Zhu, Lei Cai, Jinqi Liu, Wen Zhu, Chun Cui, Daofu Ouyang, Jianwen Ye · 2023 · International Journal of Biological Macromolecules
  49. Evidence that Alzheimer’s Disease Is a Disease of Competitive Synaptic Plasticity Gone Awry
    Zhen Huang · 2024 · Journal of Alzheimer s Disease
  50. Potential Therapeutic Implications of Gelsolin in Alzheimer's Disease
    Lina Ji, Xi Zhao, Zichun Hua · 2015 · Journal of Alzheimer s Disease
  51. Transcriptional regulation of APP by apoE: To boldly go where no isoform has gone before
    Liying Corinne Lee, Michele Q. L. Goh, Edward H. Koo · 2017 · BioEssays
  52. Characterization of a 3xTg‐AD mouse model of Alzheimer's disease with the senescence accelerated mouse prone 8 (SAMP8) background
    Jessica Virgili, Meryem Lebbadi, Cyntia Tremblay, Isabelle St‐Amour, Caroline Pierrisnard, Audrey Faucher-Genest, Vincent Émond, Carl Julien, Frédéric Calon · 2018 · Synapse
  53. The Impact of Phytosterols on the Healthy and Diseased Brain
    Tess Dierckx, Jeroen F. J. Bogie, Jerome J. A. Hendriks · 2018 · Current Medicinal Chemistry
  54. Assessing Neuroprotective Agents for Aβ-Induced Neurotoxicity
    Kelly H. Forest, Robert A. Nichols · 2019 · Trends in Molecular Medicine
  55. Apolipoprotein E impairs amyloid‐β fibril elongation and maturation
    Tohidul Islam, Anna L. Gharibyan, Solmaz Surano, Nina Pettersson, Kristoffer Brännström, Isabell Hedberg, Merit‐Miriam Virta, Linnea Olofsson, Anders Olofsson · 2019 · FEBS Journal
  56. Hormonal modulators of glial ABCA1 and apoE levels
    Jianjia Fan, Yoko Shimizu, Jeniffer Y. Chan, Anna Wilkinson, Ayaka Ito, Peter Tontonoz, Edie M. Dullaghan, Liisa A.M. Galea, Tom A. Pfeifer, Cheryl Lea Wellington · 2013 · Journal of Lipid Research
  57. Indole Compound NC009-1 Augments APOE and TRKA in Alzheimer’s Disease Cell and Mouse Models for Neuroprotection and Cognitive Improvement
    Yi-Chun Chen, Ya‐Jen Chiu, Chih‐Hsin Lin, Wen‐Chuin Hsu, Jia-Lu Wu, Chen-Hsiang Huang, Chia-Wei Lin, Ching‐Fa Yao, Hei-Jen Huang, Yen‐Shi Lo et al. · 2019 · Journal of Alzheimer s Disease
  58. Association of aBACE1Gene Polymorphism with Parkinson’s Disease in a Norwegian Population
    Johannes Lange, Kristin Aaser Lunde, Camilla Sletten, Simon Geir Møller, Ole‐Bjørn Tysnes, Guido Werner Alves, Jan Petter Larsen, Jodi Maple‐Grødem · 2015 · Parkinson s Disease
  59. Study of Exosomes Shed New Light on Physiology of Amyloidogenesis
    Guillaume van Niel · 2016 · Cellular and Molecular Neurobiology
  60. Cerebrospinal Fluid Proteins as Regulators of Beta‐amyloid Aggregation and Toxicity
    Kayla M. Pate, Regina M. Murphy · 2017 · Israel Journal of Chemistry
  61. Cognitive functions, lipid profile, and Apolipoprotein E gene polymorphism in postmenopausal women
    Iwona Bojar, Jakub Owoc, Alfred Owoc, Angelina Wójcik‐Fatla, Grzegorz Raszewski, Jaroslav Stančiak, Dorota Raczkiewicz · 2015 · Annals of Agricultural and Environmental Medicine
  62. Selective modulation of amyloid‐β peptide degradation by flurbiprofen, fenofibrate, and related compounds regulates Aβ levels
    Samer O. Abdul‐Hay, Praneeth D. Edirisinghe, Gregory R. J. Thatcher · 2009 · Journal of Neurochemistry
  63. Apolipoprotein E-dependent load of white matter hyperintensities in Alzheimer’s disease: a voxel-based lesion mapping study
    Katrin Morgen, Michael Schneider, Lutz Frölich, Heike Tost, Michael M. Plichta, Heike Kölsch, Fabian Rakebrandt, Otto Rienhoff, Frank Jessen, Oliver Peters et al. · 2015 · Alzheimer s Research & Therapy
  64. TRPC Channels and Alzheimer’s Disease
    Rui Lu, He Qian, Junfeng Wang · 2017 · Advances in experimental medicine and biology
  65. Sterol Lipid Metabolism in Down Syndrome Revisited: Down Syndrome Is Associated with a Selective Reduction in Serum Brassicasterol Levels
    Gavin Tansley, Daniel Thomas Holmes, Dieter Lütjohann, Elizabeth Head, Cheryl Lea Wellington · 2012 · Current Gerontology and Geriatrics Research
  66. Synthesis and Biological Evaluation of Hydroxylated Monocarbonyl Curcumin Derivatives as Potential Inducers of Neprilysin Activity
    Dimitris Matiadis, See-Ting Ng, Eric H.-L. Chen, Georgia Nigianni, Veroniki P. Vidali, Aleksander Canko, Rita P.‐Y. Chen, Marina Sagnou · 2021 · Biomedicines
  67. It Is Time to Study Overlapping Molecular and Circuit Pathophysiologies in Alzheimer’s and Lewy Body Disease Spectra
    Noritaka Wakasugi, Takashi Hanakawa · 2021 · Frontiers in Systems Neuroscience
  68. Revisiting APP secretases: an overview on the holistic effects of retinoic acid receptor stimulation in APP processing
    José J. M. Vitória, Diogo Trigo, Odete A. B. da Cruz e Silva · 2022 · Cellular and Molecular Life Sciences
  69. Retinoid X Receptor Alpha Nitro-ligand Z-10 and Its Optimized Derivative Z-36 Reduce β-Amyloid Plaques in Alzheimer’s Disease Mouse Model
    Gaoang Ren, Wei Bao, Zhiping Zeng, Weidong Zhang, Ce Shang, Maosi Wang, Ying Su, Xiao-kun Zhang, Hu Zhou · 2018 · Molecular Pharmaceutics
  70. ApoE and clusterin CSF levels influence associations between APOE genotype and changes in CSF tau, but not CSF Aβ42, levels in non-demented elderly
    Rosalinde E.R. Slot, Maartje I. Kester, Argonde C. van Harten, Wesley Jongbloed, Femke H. Bouwman, Charlotte Elisabeth Teunissen, Philip Scheltens, Wiesje M. van der Flier, Robert Veerhuis · 2019 · Neurobiology of Aging
  71. The Associations of Cerebrospinal Fluid ApoE and Biomarkers of Alzheimer’s Disease: Exploring Interactions With Sex
    Ying Liu, Jinghui Song, Wei Xu, Xiao‐He Hou, Jieqiong Li, Jin‐Tai Yu, Lan Tan, Song Chi, and Alzheimer’s Disease Neuroimaging Initiative · 2021 · Frontiers in Neuroscience
  72. Endogenous Human Proteins Interfering with Amyloid Formation
    Anna L. Gharibyan, Sanduni Wasana Jayaweera, Manuela Lehmann, Intissar Anan, Anders Olofsson · 2022 · Biomolecules
  73. Cognitive and Neuropsychological Profiles in Alzheimer’s Disease and Primary Age-Related Tauopathy and the Influence of Comorbid Neuropathologies
    Jamie M. Walker, Mitzi M. Gonzales, William F. Goette, Kurt W. Farrell, Charles L. White, John F. Crary, Timothy E. Richardson · 2023 · Journal of Alzheimer s Disease
  74. Analysis of Genome-Wide Association Study (GWAS) data looking for replicating signals in Alzheimer's disease (AD).
    Hui Shi, Christopher Medway, James M. Bullock, Kristelle S. Brown, Noor A Kalsheker, Kevin Morgan · 2010 · PubMed Central
  75. Daily rhythms of cognition-related factors are modified in an experimental model of Alzheimer’s disease
    Lorena Navigatore-Fonzo, Andrea Castro, Verónica Pignataro, Marisa Hilda Garraza, Marilina Casais, Ana Cecilia Anzulovich · 2017 · Brain Research
  76. Insulin Action in the Brain and the Pathogenesis of Alzheimer’s Disease
    C. Ronald Kahn, Ryo Suzuki · 2010 · Research and perspectives in Alzheimer's disease
  77. Enlargement of Aβ aggregates through chemokine-dependent microglial clustering
    Wei-Chao Huang, Feng-Chang Yen, Young‐Ji Shiao, Feng‐Shiun Shie, Jin-Lieh Chan, Cheng-Ning Yang, Yen-Jen Sung, Fong-Lee Huang, Huey-Jen Tsay · 2009 · Neuroscience Research
  78. The Pathological Cross Talk Between Apolipoprotein E and Amyloid-β Peptide in Alzheimer's Disease: Emerging Gene-Based Therapeutic Approaches
    Sandra Iurescia, Daniela Piergili Fioretti, Francesca Mangialasche, Monica Rinaldi · 2010 · Journal of Alzheimer s Disease
  79. Engineered Stem Cell Membrane-Coated Nanodrugs for Targeted Therapy of Alzheimer’s Disease
    Shuang Sha, Chunbin Sun, Xiaoyu Gao, Wangyu Bi, Hongyu Chen, Weijie Ren, Lei Wang, Enli Luo, Cencan Xing, Hongwu Du · 2025 · ACS Applied Materials & Interfaces
  80. APOE Lipoprotein Particles: Pathophysiology, Therapy, and the Crosstalk in Alzheimer’s Disease and Cardiovascular Disease
    Чан Лю, Juan Liu, Yanyang Wang, Shang-Fu Xu, Li-Mei Yu · 2025 · Molecular Neurobiology
  81. Depression and APOEε4 Status in Individuals with Subjective Cognitive Decline: A Meta-Analysis
    Yueping Huang, Jujun Xue, Chao Li, Xi Chen, Hongjuan Fu, Teng Fei, Peng-xiang Bi · 2020 · Psychiatry Investigation
  82. Alzheimer’s disease pathogenetic progression is associated with changes in regulated retained introns and editing of circular RNAs
    Karol Andrea Arizaca Maquera, Justin Ralph Welden, Giorgi Margvelani, Sandra C. Miranda Sardón, Samantha N. Hart, Noémie Robil, Alvaro Gonzalo Hernandez, Pierre de la Grange, Peter T. Nelson, Stefan Stamm · 2023 · Frontiers in Molecular Neuroscience
  83. Failure, Success, and Future Direction of Alzheimer Drugs Targeting Amyloid‐β Cascade: Pros and Cons of Chemical and Biological Modalities
    Jimin Kim, Hanna Jeon, Hye Yun Kim, Young Soo Kim · 2023 · ChemBioChem
  84. Retracted: Advances in the physiological and pathological implications of cholesterol
    Víctor Cortés, Dolores Busso, Pablo Mardones, Alberto Maiz G, Antonio Arteaga, Flavio O. Nervi, Attilio Rigotti · 2013 · Biological reviews/Biological reviews of the Cambridge Philosophical Society · Retracted
  85. Impaired plasmalogen synthesis dysregulates liver X receptor-dependent transcription in cerebellum
    Masanori Honsho, Fabian Dorninger, Yuichi Abe, Daiki Setoyama, Ryohei Ohgi, Takeshi Uchiumi, Dongchon Kang, Johannes Berger, Yukio Fujiki · 2019 · The Journal of Biochemistry
  86. Bexarotene Impairs Cognition and Produces Hypothyroidism in a Mouse Model of Down Syndrome and Alzheimer’s Disease
    Verónica Vidal, Alba Puente, Susana García-Cerro, María Teresa García‐Unzueta, Noemı́ Rueda, Javier Riancho, Carmen Martínez‐Cué · 2021 · Frontiers in Pharmacology
  87. Liver X receptor agonist T0901317 reduces neuropathological changes and improves memory in mouse models of experimental dementia
    Rupinder Kaur Sodhi, Nirmal Singh · 2014 · European Journal of Pharmacology
  88. Fatty acid-based lipidomics and membrane remodeling induced by apoE3 and apoE4 in human neuroblastoma cells
    Prasinou, Paraskevi, Dafnis, Ioannis, Giacometti, Giorgia, Ferreri, Carla, Chroni, Angeliki, Chatgilialoglu, Chryssostomos · 2017 · Biochimica et Biophysica Acta (BBA) - Biomembranes
  89. Genetic and environmental risk factors for dementia in African adults: A systematic review
    David Mawutor Donkor, Esther Marfo, Ansumana Sandy Bockarie, Edward Jenner Tettevi, Maxwell Hubert Antwi, John Dogah, George Nkrumah Osei, David Larbi Simpong · 2025 · Alzheimer s & Dementia
  90. Tract Based Spatial Statistic Reveals No Differences in White Matter Microstructural Organization between Carriers and Non-Carriers of the APOE ɛ4 and ɛ2 Alleles in Young Healthy Adolescents
    Flavio Dell’Acqua, Wasim Khan, Natalie Gottlieb, Vincent Giampietro, Cedric E. Ginestet, David Bouls, Stephen Newhouse, Richard Dobson, Tobias Banaschewski, Gareth J. Barker et al. · 2015 · Journal of Alzheimer s Disease
  91. Decreased Inter-Hemispheric Functional Connectivity in Cognitively Intact Elderly APOE ɛ 4 Carriers: A Preliminary Study
    Xiao Luo, Tiantian Qiu, Xiaojun Xu, Peiyu Huang, Quanquan Gu, Zhujing Shen, Xinfeng Yu, Yunlu Jia, Xiaojun Guan, Ruirui Song et al. · 2016 · Journal of Alzheimer s Disease
  92. RARβ Agonist Drug (C286) Demonstrates Efficacy in a Pre-clinical Neuropathic Pain Model Restoring Multiple Pathways via DNA Repair Mechanisms
    Maria Beatriz C.V. Goncalves, Julien Moehlin, Earl E. Clarke, John Grist, Carl Hobbs, Antony M. Carr, Julian Jack, Marco Antonio Mendoza-Parra, Jonathan P. T. Corcoran · 2019 · iScience
  93. CSF cutoffs for MCI due to AD depend on APOEε4 carrier status
    Moira Marizzoni, Clarissa Ferrari, Claudio Babiloni, Diego Albani, Frederik Barkhof, Libera Cavaliere, Mira Didic, Gianluigi Forloni, Federica Fusco, Samantha Galluzzi et al. · 2019 · Neurobiology of Aging
  94. MSR1 and NEP Are Correlated with Alzheimer’s Disease Amyloid Pathology and Apolipoprotein Alterations
    Justin Miron, Cynthia Picard, Anne Labonté, Daniel S. Auld, Judes Poirier · 2022 · Journal of Alzheimer s Disease
  95. Curcumin ameliorates lipid metabolic disorder and cognitive dysfunction via the ABCA1 transmembrane transport system in APP/PS1 double transgenic mice
    Mingyuan Tian, Fanlin Zhou, Zhipeng Teng, Chen Wang, Xiong Zhang, Yangyang Wang, Yu Li · 2021 · Journal of Integrative Neuroscience
  96. A review of imaging genetics in Alzheimer's disease
    Xin Yu, Jinhua Sheng, Miao Miao, Luyun Wang, Ze Xiao Yang, He Huang · 2022 · Journal of Clinical Neuroscience
  97. Deciphering an interplay of proteins associated with amyloid β 1-42 peptide and molecular mechanisms of Alzheimer’s disease
    Luis Fernando Hernández-Zimbrón, Selva Rivas-Arancibia · 2014 · Reviews in the Neurosciences
  98. Postmenopausal cognitive changes and androgen levels in the context of apolipoprotein E polymorphism
    Iwona Bojar, Jarosław Pinkas, Mariusz Gujski, Alfred Owoc, Dorota Raczkiewicz, Kasia Gustaw Rothenberg · 2016 · Archives of Medical Science
  99. Effects of an Aβ-antibody fragment on Aβ aggregation and astrocytic uptake are modulated by apolipoprotein E and J mimetic peptides
    Laia Montoliu‐Gaya, Sandra D. Mulder, Robert Veerhuis, Sandra Villegas · 2017 · PLoS ONE
  100. Development of new treatments for Alzheimer’s disease based on the modulation of translocator protein (TSPO)
    Bruno Dutra Arbo, Maria Flávia Marques Ribeiro, Luis Miguel García‐Segura · 2019 · Ageing Research Reviews